Drug Coupons: A Good Deal For The Patient, But Not The Insurer
Makers of brand-name prescription drugs often offer discounts to help defray patients' co-pay costs, but insurers say that drives up their overall health spending.
The independent source for health policy research, polling, and news.
2,781 - 2,800 of 3,484 Results
Makers of brand-name prescription drugs often offer discounts to help defray patients' co-pay costs, but insurers say that drives up their overall health spending.
With time running out, 17 states and D.C. commit to setting up the new markets, eight are undecided and the rest weigh partnering with the federal government -- or letting the feds take over.
The president's victory cements the Affordable Care Act, expanding coverage to millions but leaving weighty questions about how to pay for it.
But the status quo on Capitol Hill doesn't mean that the parties are unwilling to work on health care issues.
State lawmakers will control big coverage decisions, including whether to expand Medicaid to cover millions of uninsured.
Insurers are spending big dollars on marketing, technology and risk analysis of the new health care landscape. But with exchanges supposed to go live in late 2013, where and how companies will plunge - and how deep - is far from clear.
This metaphor may be useful in decoding the gradations and complexities of insurance coverage and access to care.
Congress would probably look for cuts in the health care program for seniors and the disabled as it seeks to find ways to curb federal spending.
KHN hosts a discussion on the Obama and Romney plans with former Democratic Sen. Tom Daschle and conservative health care analyst Avik Roy, followed by a reporters' roundtable with KHN's Mary Agnes Carey and Sarah Varney, Karen Tumulty of the Washington Post and Politico's Jonathan Allen.
State experiment gets scrutiny amid national debate over role of insurance regulation in rising coverage costs.
© 2026 KFF